Neuspera Medical, formerly known as Vivonda Medical, is a medical product manufacturer focused on developing injectable neuromodulation devices, also known as 'electroceuticals.' Utilizing licensed mid-field powering technology, Neuspera's core mission is to address Urinary Urgency Incontinence (UUI), a symptom of Overactive Bladder (OAB), through a patient-first approach. Their minimally invasive devices aim to improve bladder control and enhance the quality of life for those affected by these conditions.
Neuspera Medical has made significant strides in the field of neuromodulation with its innovative and modern solutions. The company's commitment to addressing UUI through advanced technology has positioned it as a leader in the medical device industry. By focusing on patient needs and leveraging cutting-edge technology, Neuspera continues to impact the lives of individuals seeking better management of bladder control issues.
